Role of glucagon in the splanchnic and systemic hemodynamic changes induced by portal-systemic blood shunting.
Portal-systemic blood shunting is often accompanied by hyperglucagonemia and hemodynamic changes. To determine this causal relation, splanchnic and systemic hemodynamics (radioactive microspheres) and plasma glucagon levels (radioimmunoassay) were assessed in conditions of total portal-systemic shunting in portacaval-shunted (PCS) rats and in sham-operated (SO) normal rats. To compare these results, another hemodynamic study was undertaken basally and during glucagon infusion in nonoperated normal rats. PCS rats showed a threefold greater plasma glucagon concentration than SO animals (924 +/- 134 vs. 309 +/- 18 pg/ml, p less than 0.01), and they developed a hyperdynamic splanchnic circulation with higher portal venous inflow than SO rats (8.29 +/- 1.1 vs. 5.09 +/- 0.4 ml/min/100 g, p less than 0.05). Infusion of a pharmacological dose of glucagon in normal rats increased portal venous inflow (from 4.92 +/- 0.33 to 6.24 +/- 0.48 ml/min/100 g, p less than 0.05) so as to imply this hormone in the development of the hyperdynamic splanchnic circulation in conditions of portal-systemic shunting. However, the discrepancies in systemic hemodynamics between PCS and glucagon-infused rats may be a result of the different plasma glucagon levels reached in the two groups.
Romeo
J M
JM
Department of Surgery, Jimenez Diaz Foundation CSIC, Madrid, Spain.
Lopez-Farre
A
A
Martin-Paredero
V
V
Lopez-Novoa
J M
JM
D000818:Animals; D002302:Cardiac Output; D005934:Glucagon / Q000494:pharmacology / Q000502:physiology*; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology*; D008297:Male; D011170:Portasystemic Shunt, Surgical; D051381:Rats; D011919:Rats, Inbred Strains; D013152:Splanchnic Circulation / Q000187:drug effects / Q000502:physiology*; D014655:Vascular Resistance
D005934:Glucagon